by admin | Dec 1, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Drug Target Review Immunotherapy, the promising therapy which harnesses the power of the body’s immune response to target cancer cells, may be advanced by a new minifridge bioreactor developed by researchers at Washington State University. This bioreactor can...
by admin | Nov 30, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By UNSW Newsroom The ‘Trpzip’ material will reform after being squished, fractured, or after being expelled from a syringe. Photo: UNSW Sydney Scientists at UNSW Sydney have created a new material that could change the way human tissue can be grown in the...
by admin | Nov 27, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Waterloo News People who have experienced significant muscle damage have new hope thanks to Evolved.Bio, a startup that has developed innovative technology that can regenerate muscle tissue in a highly effective way. Other biotech companies use natural or synthetic...
by admin | Nov 24, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Felix Myhill – RegMedNet Researchers at the University of California, Los Angeles (UCLA; CA, USA) have produced safe and effective allogeneic immune cells that one day may be mobilized to combat cancer. Allogeneic cell therapies differ from autologous cell...
by admin | Nov 23, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Mayo Clinic’s Discovery’s Edge Mayo Clinic researchers and collaborators have identified a protein expressed by immune cells that may play a key role in the development of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease....
by admin | Nov 22, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Gina Kolata – The New York Times The first treatment that relies on CRISPR is expected to receive U.S. approval next month. But it may cost millions of dollars per patient. Regulators in Britain on Thursday approved the first treatment derived from CRISPR,...
